Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice
Apel, Arie, Moshe, Yakir, Ofran, Yishai, Gural, Alexander, Wolach, Ofir, Ganzel, Chezi, Canaani, Jonathan, Zektser, Miri, Duek, Adrian, Stemer, Galia, Hellman, Ilana, Basood, May, Frisch, Avraham, Leibovitch, Chiya, Koren‐Michowitz, Maya
Published in American journal of hematology (01.07.2021)
Published in American journal of hematology (01.07.2021)
Get full text
Journal Article
P560: IMPROVEMENT IN OVERALL AND RELAPSE FREE SURVIVAL OF AML PATIENTS OVER THE AGE OF 75 SINCE THE APPROVAL OF VENETOCLAX IN A REAL‐WORLD SINGLE CENTER STUDY
Moshe, Yakir, Levi, Shai, Neeman, Miri, Gat, Roi, Levi, Mor, Eilati, Nili, Shragai, Tamir, Basood, May, Segman, Yafit, Baron, Yaeli, Luttwak, Efrat, Neuman, Tsipora, Vitkon, Roy, Mittelman, Moshe, Avivi, Irit
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Inhibition of MAPK-ERK Signaling Pathway Overcomes Microrna-Mediated Ibrutinib Resistance in Mantle Cell Lymphoma
Kersy, Olga, Salmon-Divon, Mali, Gomes da Silva, Maria, Moita, Ana Filipa, Cabecadas, Jose, Klener, Pavel, Trněný, Marek, Basood, May, Shpilberg, Ofer, Hershkovitz-Rokah, Oshrat
Published in Blood (15.11.2022)
Published in Blood (15.11.2022)
Get full text
Journal Article
The effect of methylation on the let-7-BCL2L1-BCL2 axis and the potential use of hypomethylating and BH3 mimetic drugs in histiocytic neoplasms
Salmon-Divon, Mali, Meyuchas, Refael, Shpilberg, Ofer, Okon, Elimelech, Benhamida, Jamal, Yabe, Mariko, Petrova-Drus, Kseniya, Zvida-Bloch, Tal, Basood, May, Mazor, Roei, Durham, Benjamin H, Haroche, Julien, Abdel-Wahab, Omar, Diamond, Eli L, Hershkovitz-Rokah, Oshrat
Published in Leukemia (08.11.2024)
Published in Leukemia (08.11.2024)
Get full text
Journal Article